Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2396663
Max Phase: Preclinical
Molecular Formula: C28H34N2O
Molecular Weight: 414.59
Molecule Type: Small molecule
Associated Items:
ID: ALA2396663
Max Phase: Preclinical
Molecular Formula: C28H34N2O
Molecular Weight: 414.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
Standard InChI: InChI=1S/C28H34N2O/c1-3-21-30(27-18-12-23(4-2)13-19-27)22-9-8-20-29-28(31)26-16-14-25(15-17-26)24-10-6-5-7-11-24/h2,5-7,10-12,14-17,27H,3,8-9,13,18-22H2,1H3,(H,29,31)/t27-/m1/s1
Standard InChI Key: PWZPBZQTTHOCIS-HHHXNRCGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 414.59 | Molecular Weight (Monoisotopic): 414.2671 | AlogP: 5.69 | #Rotatable Bonds: 10 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.91 | CX LogP: 5.49 | CX LogD: 2.28 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.40 | Np Likeness Score: -0.76 |
1. Hiller C, Kling RC, Heinemann FW, Meyer K, Hübner H, Gmeiner P.. (2013) Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety., 56 (12): [PMID:23730937] [10.1021/jm400520c] |
2. Weichert D, Banerjee A, Hiller C, Kling RC, Hübner H, Gmeiner P.. (2015) Molecular determinants of biased agonism at the dopamine D₂ receptor., 58 (6): [PMID:25734236] [10.1021/jm501889t] |
Source(1):